Claritev Stock Technical Analysis
| CTEV Stock | 30.05 1.20 4.16% |
As of the 23rd of January, Claritev shows the risk adjusted performance of (0.06), and Mean Deviation of 5.28. Claritev technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Claritev risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Claritev is priced correctly, providing market reflects its regular price of 30.05 per share. Given that Claritev has information ratio of (0.1), we suggest you to validate Claritev's prevailing market performance to make sure the company can sustain itself at a future point.
Claritev Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Claritev, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ClaritevClaritev's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Claritev Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 57.25 | Buy | 2 | Odds |
Most Claritev analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Claritev stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Claritev, talking to its executives and customers, or listening to Claritev conference calls.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Claritev. If investors know Claritev will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Claritev listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (20.91) | Revenue Per Share | Quarterly Revenue Growth 0.067 | Return On Assets | Return On Equity |
The market value of Claritev is measured differently than its book value, which is the value of Claritev that is recorded on the company's balance sheet. Investors also form their own opinion of Claritev's value that differs from its market value or its book value, called intrinsic value, which is Claritev's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Claritev's market value can be influenced by many factors that don't directly affect Claritev's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Claritev's value and its price as these two are different measures arrived at by different means. Investors typically determine if Claritev is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Claritev's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Claritev 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Claritev's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Claritev.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in Claritev on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding Claritev or generate 0.0% return on investment in Claritev over 90 days. Claritev is related to or competes with Goodrx Holdings, Opko Health, Evolent Health, Integra LifeSciences, Sana Biotechnology, Iradimed, and Axogen. Claritev is entity of United States. It is traded as Stock on NYSE exchange. More
Claritev Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Claritev's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Claritev upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 37.38 | |||
| Value At Risk | (13.45) | |||
| Potential Upside | 10.91 |
Claritev Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Claritev's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Claritev's standard deviation. In reality, there are many statistical measures that can use Claritev historical prices to predict the future Claritev's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.54) | |||
| Total Risk Alpha | (1.33) | |||
| Treynor Ratio | 0.4094 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Claritev's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Claritev January 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | 0.4194 | |||
| Mean Deviation | 5.28 | |||
| Coefficient Of Variation | (1,133) | |||
| Standard Deviation | 7.28 | |||
| Variance | 52.97 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (0.54) | |||
| Total Risk Alpha | (1.33) | |||
| Treynor Ratio | 0.4094 | |||
| Maximum Drawdown | 37.38 | |||
| Value At Risk | (13.45) | |||
| Potential Upside | 10.91 | |||
| Skewness | (0.86) | |||
| Kurtosis | 1.59 |
Claritev Backtested Returns
Claritev secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16 % return per unit of standard deviation over the last 3 months. Claritev exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Claritev's mean deviation of 5.28, and Risk Adjusted Performance of (0.06) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -1.59, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Claritev are expected to decrease by larger amounts. On the other hand, during market turmoil, Claritev is expected to outperform it. At this point, Claritev has a negative expected return of -1.2%. Please make sure to confirm Claritev's potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if Claritev performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.49 |
Average predictability
Claritev has average predictability. Overlapping area represents the amount of predictability between Claritev time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Claritev price movement. The serial correlation of 0.49 indicates that about 49.0% of current Claritev price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.49 | |
| Spearman Rank Test | 0.43 | |
| Residual Average | 0.0 | |
| Price Variance | 26.81 |
Claritev technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Claritev Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Claritev volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Claritev Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Claritev on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Claritev based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Claritev price pattern first instead of the macroeconomic environment surrounding Claritev. By analyzing Claritev's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Claritev's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Claritev specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 32.17 | 43.77 | 39.4 | 25.13 | PTB Ratio | 0.28 | 5.61 | 5.05 | 5.3 |
Claritev January 23, 2026 Technical Indicators
Most technical analysis of Claritev help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Claritev from various momentum indicators to cycle indicators. When you analyze Claritev charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | 0.4194 | |||
| Mean Deviation | 5.28 | |||
| Coefficient Of Variation | (1,133) | |||
| Standard Deviation | 7.28 | |||
| Variance | 52.97 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (0.54) | |||
| Total Risk Alpha | (1.33) | |||
| Treynor Ratio | 0.4094 | |||
| Maximum Drawdown | 37.38 | |||
| Value At Risk | (13.45) | |||
| Potential Upside | 10.91 | |||
| Skewness | (0.86) | |||
| Kurtosis | 1.59 |
Claritev January 23, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Claritev stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.08 | ||
| Daily Balance Of Power | 0.47 | ||
| Rate Of Daily Change | 1.04 | ||
| Day Median Price | 30.30 | ||
| Day Typical Price | 30.21 | ||
| Price Action Indicator | 0.36 | ||
| Market Facilitation Index | 2.53 |
Additional Tools for Claritev Stock Analysis
When running Claritev's price analysis, check to measure Claritev's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Claritev is operating at the current time. Most of Claritev's value examination focuses on studying past and present price action to predict the probability of Claritev's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Claritev's price. Additionally, you may evaluate how the addition of Claritev to your portfolios can decrease your overall portfolio volatility.